{"id":161,"date":"2021-06-30T14:14:32","date_gmt":"2021-06-30T14:14:32","guid":{"rendered":"https:\/\/mims.parabolasolution.com\/?page_id=161"},"modified":"2026-04-01T15:56:43","modified_gmt":"2026-04-01T07:56:43","slug":"1l-metastatic-recurrent-nsclc-with-chemo","status":"publish","type":"page","link":"https:\/\/bms.mimsit.net\/dosing\/1l-metastatic-recurrent-nsclc-with-chemo\/","title":{"rendered":"1L metastatic\/recurrent NSCLC (with chemo)"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"161\" class=\"elementor elementor-161\" data-elementor-settings=\"[]\">\n\t\t\t\t\t\t\t<div class=\"elementor-section-wrap\">\n\t\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-1393621e elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"1393621e\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-2ea0f9cd\" data-id=\"2ea0f9cd\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-5e7812f9 elementor-widget elementor-widget-text-editor\" data-id=\"5e7812f9\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.5.5 - 03-02-2022 *\/\n.elementor-widget-text-editor.elementor-drop-cap-view-stacked .elementor-drop-cap{background-color:#818a91;color:#fff}.elementor-widget-text-editor.elementor-drop-cap-view-framed .elementor-drop-cap{color:#818a91;border:3px solid;background-color:transparent}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap{margin-top:8px}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap-letter{width:1em;height:1em}.elementor-widget-text-editor .elementor-drop-cap{float:left;text-align:center;line-height:1;font-size:50px}.elementor-widget-text-editor .elementor-drop-cap-letter{display:inline-block}<\/style>\t\t\t\t<p><!-- wp:html --><\/p>\n<figure class=\"wp-block-image size-full img-fluid is-style-default\"><a class=\"foobox text-dark\" href=\"http:\/\/bms.mimsit.net\/dosing\/wp-content\/uploads\/2021\/06\/fig_1LmetastaticRecurrentNSCLCwithChemo.jpg\"> <img loading=\"lazy\" decoding=\"async\" width=\"1910\" height=\"950\" class=\"wp-image-162\" src=\"http:\/\/bms.mimsit.net\/dosing\/wp-content\/uploads\/2021\/06\/fig_1LmetastaticRecurrentNSCLCwithChemo.jpg\" alt=\"\" srcset=\"https:\/\/bms.mimsit.net\/dosing\/wp-content\/uploads\/2021\/06\/fig_1LmetastaticRecurrentNSCLCwithChemo.jpg 1910w, https:\/\/bms.mimsit.net\/dosing\/wp-content\/uploads\/2021\/06\/fig_1LmetastaticRecurrentNSCLCwithChemo-300x149.jpg 300w, https:\/\/bms.mimsit.net\/dosing\/wp-content\/uploads\/2021\/06\/fig_1LmetastaticRecurrentNSCLCwithChemo-1024x509.jpg 1024w, https:\/\/bms.mimsit.net\/dosing\/wp-content\/uploads\/2021\/06\/fig_1LmetastaticRecurrentNSCLCwithChemo-768x382.jpg 768w, https:\/\/bms.mimsit.net\/dosing\/wp-content\/uploads\/2021\/06\/fig_1LmetastaticRecurrentNSCLCwithChemo-1536x764.jpg 1536w\" sizes=\"auto, (max-width: 1910px) 100vw, 1910px\" \/><\/a><\/figure>\n<p><!-- \/wp:verse --><\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-96343d4 elementor-widget elementor-widget-text-editor\" data-id=\"96343d4\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p>1L, first-line; AUC, area under the curve; chemo, chemotherapy; IV, intravenous; NSCLC, non-small cell lung cancer; PD, progressive disease; Pt, platinum; QxW, every x weeks.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-aeb90e2 elementor-section-content-middle elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"aeb90e2\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-8e9c1b7\" data-id=\"8e9c1b7\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-f32785c elementor-widget elementor-widget-text-editor\" data-id=\"f32785c\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p>1. Opdivo<sup>\u00ae<\/sup> (nivolumab). Hong Kong Prescribing Information; Hong Kong: Bristol-Myers Squibb.<\/p>\n<p>2. Data on file. NIVO 608. Princeton, NJ: Bristol Myers Squibb Company; 2020.<\/p>\n<p>3. Yervoy\u00ae (ipilimumab). Hong Kong Prescribing Information; Hong Kong: Bristol-Myers Squibb.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-inner-column elementor-element elementor-element-4e3bfad\" data-id=\"4e3bfad\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-dbcded5 elementor-widget__width-auto elementor-widget elementor-widget-image\" data-id=\"dbcded5\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.5.5 - 03-02-2022 *\/\n.elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=\".svg\"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block}<\/style>\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"225\" height=\"225\" src=\"https:\/\/bms.mimsit.net\/dosing\/wp-content\/uploads\/2026\/02\/qr-opdivo-feb-27-2026.png\" class=\"attachment-large size-large\" alt=\"\" srcset=\"https:\/\/bms.mimsit.net\/dosing\/wp-content\/uploads\/2026\/02\/qr-opdivo-feb-27-2026.png 225w, https:\/\/bms.mimsit.net\/dosing\/wp-content\/uploads\/2026\/02\/qr-opdivo-feb-27-2026-150x150.png 150w\" sizes=\"auto, (max-width: 225px) 100vw, 225px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-ec594cc elementor-widget__width-auto elementor-widget elementor-widget-image\" data-id=\"ec594cc\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"144\" height=\"144\" src=\"https:\/\/bms.mimsit.net\/dosing\/wp-content\/uploads\/2026\/02\/qr-yervoy-feb-27-2026.png\" class=\"attachment-large size-large\" alt=\"\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>1L, first-line; AUC, area under the curve; chemo, chemotherapy; IV, intravenous; NSCLC, non-small cell lung cancer; PD, progressive disease; Pt, platinum; QxW, every x weeks. 1. Opdivo\u00ae (nivolumab). Hong Kong Prescribing Information; Hong Kong: Bristol-Myers Squibb. 2. Data on file. NIVO 608. Princeton, NJ: Bristol Myers Squibb Company; 2020. 3. Yervoy\u00ae (ipilimumab). Hong Kong Prescribing [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":78,"parent":0,"menu_order":10,"comment_status":"closed","ping_status":"closed","template":"page-template1.php","meta":{"footnotes":""},"class_list":["post-161","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/bms.mimsit.net\/dosing\/wp-json\/wp\/v2\/pages\/161","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bms.mimsit.net\/dosing\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/bms.mimsit.net\/dosing\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/bms.mimsit.net\/dosing\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bms.mimsit.net\/dosing\/wp-json\/wp\/v2\/comments?post=161"}],"version-history":[{"count":89,"href":"https:\/\/bms.mimsit.net\/dosing\/wp-json\/wp\/v2\/pages\/161\/revisions"}],"predecessor-version":[{"id":1816,"href":"https:\/\/bms.mimsit.net\/dosing\/wp-json\/wp\/v2\/pages\/161\/revisions\/1816"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bms.mimsit.net\/dosing\/wp-json\/wp\/v2\/media\/78"}],"wp:attachment":[{"href":"https:\/\/bms.mimsit.net\/dosing\/wp-json\/wp\/v2\/media?parent=161"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}